Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses
Authors:
- 1 September 2015
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 113 (05) , 1035-1045
Abstract
Platelets and platelet-monocyte interaction play an important role in inflammation. Both pro- and anti-inflammatory effects of platelet inhibition have been reported in animal models. This study aimed to investigate the effect of platelets and platelet inhibition by the new P2Y12 receptor antagonist ticagrelor on monocyte function, as assessed by cytokine responses to Toll-like Receptor (TLR) ligands. In a set of in vitro experiments, peripheral blood mononuclear cells (PBMC) incubated with the TLR2 ligand Pam3CSK4 produced less cytokines in the presence of platelets, whereas platelets increased the production of cytokines when PBMC were exposed to TLR4 ligand lipopolysaccharide (LPS). These effects of platelets were dependent on direct platelet-leukocyte aggregation and for the Pam3CSK4-induced response, on phagocytosis of platelets by monocytes. In a double blind, placebo-controlled crossover trial in healthy volunteers, a single oral dosage of 180 mg ticagrelor reduced platelet-monocyte complex (PMC) formation. This was associated with an increase in pro-inflammatory cytokines in blood exposed to Pam3CSK4, but a decrease in these cytokines in blood exposed to LPS. These findings show that platelets differentially modulate TLR2- and TLR4-mediated cytokine responses of PBMC. Through inhibition of platelet-leukocyte interaction, P2Y12 receptor antagonists may either exert a pro- or anti-inflammatory effect during infections depending on the TLR primarily involved.Keywords
Funding Information
- Scientific Research and an ERC Consolidator (nr. 310372)
This publication has 30 references indexed in Scilit:
- Prasugrel Reduces Agonists′ Inducible Platelet Activation and Leukocyte–Platelet Interaction more efficiently than ClopidogrelCardiovascular Therapeutics, 2013
- Platelets as Cellular Effectors of Inflammation in Vascular DiseasesCirculation Research, 2013
- Purinergic Signaling during InflammationNew England Journal of Medicine, 2012
- The Repertoire and Features of Human Platelet microRNAsPLOS ONE, 2012
- Platelets and platelet-like particles mediate intercellular RNA transferBlood, 2012
- Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide-Induced ArthritisPLOS ONE, 2011
- Modulation of Toll-Like Receptor 2 (TLR2) and TLR4 Responses byAspergillus fumigatusInfection and Immunity, 2009
- Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanismsPlatelets, 2009
- Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in miceCritical Care, 2007
- Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine MacrophagesInfection and Immunity, 2001